The effects of tumour necrosis factor-a (TNFa) on the growth and DNA synthesis of the human breast cell line, T47D, were studied. A dose-dependent, reversible inhibition of thymidine incorporation and cell growth was observed in the range of 0.1 ng ml-I to 100 ng ml-of TNFa. Cell viability was not impaired in any of the experiments. Flow-cytometric DNA analysis demonstrated that after 24 h exposure to TNFa, T47D cells accumulated in the GI phase of the cell cycle, and were depleted in the G2/M and S phases, suggesting a block in the progression of the GI/S transition. The involvement of protein kinases (PK) and protein phosphatases in TNFa-induced signal transduction was also investigated. A transient and rapid 2-fold increase in total cellular protein kinase C (PKC) activity was detected after 10min exposure to TNFa. To study the role of the observed PKC activation in the cytostatic effect of TNFa, T47D cells were exposed to the cytokine in the presence of the potent PKC inhibitor, H7. The inhibitory effect of TNFa on thymidine incorporation was not affected by exposure to H7 at concentrations sufficient to block the stimulation of thymidine up-take induced by the PKC agonist, phorbol-12-myristate-13-acetate (PMA). The involvement of other signalling pathways was addressed using the cyclic nucleotide-dependent PK inhibitor, H8; the calmodulin-dependent PK inhibitor, W7; and the inhibitor of protein phosphatases PPI and PP2B, okadaic acid. Exposure of T47D cells to these enzyme inhibitors failed to antagonise the inhibition of thymidine incorporation by TNFa. Taken together, these results indicate that the cytostatic effect of TNFa on T47D cells occurs at the GI/S transition of the cell cycle, and is mediated by an intracellular pathway which does not involve the activity of protein kinases C and A, nor protein phosphatases PP1, PP2B.
Tumour necrosis factor-a (TNFa) is a polypeptide which exerts a variety of biological effects (Balkwill, 1989) . Numerous studies have shown that TNFx inhibits the growth of various cancer cell lines in vivo by both a cytolytic and a cytostatic mechanism (Sugarman et al., 1985; Fransen et al., 1986 , Browning & Ribolini, 1989 . Previous studies have indicated that cells which are lysed by TNFa are first blocked at the postsynthetic G2, M phases of the cell cycle, and that cells accumulating in S or M phases subsequently undergo cell death (Darzynkiewicz et al., 1984; Dealtry et al., 1987; Muro et al., 1991) . Several cellular mechanisms have been proposed to explain the cytolytic effect of TNFa (for review: Larrick & Wright, 1990) . However, little is known of the cellular mechanisms mediating the reversible cytostatic effect of this cytokine and the associated signal transduction pathways.
Several lines of evidence suggest that protein kinase(s) are involved in TNFa signal transduction. Although TNFa rapidly induces serine phosphorylation of a variety of cellular proteins (Hepburn et al., 1988; Marino et al., 1989; Schutze et al., 1989;  Arrigo, 1990) , the protein kinase(s) responsible for this remain elusive. Protein kinase C (PKC) has been implicated in several actions of TNFa Zucali et al., 1990; Elbaz et al., 1991; Sancho & Terranova, 1991) ; phorbol-myristate-acetate (PMA), a potent PKC agonist, mimics numerous biological effects of this cytokine. Nevertheless, PKC activation seems only to simulate the effects of TNFa in most cases, and does not mediate it directly (Oka & Arrita, 1991; Ritchie et al., 1991) . TNFa also elevates the level of cAMP in a fibroblast cell line (Zhang et al., 1988) suggesting a possible involvement of a cAMPdependent protein kinase (PKA). However, the involvement of PKA in TNFa-induced protein phosphorylation has yet to be demonstrated (Pfeilschifter et al., 1991) . Calmodulin has also been implicated in the action of TNFo since free radical generation induced by this cytokine in human leukocytes is inhibited by calmodulin antagonists (Das et al., 1990) .
In this study the effect of TNFa on both the DNA synthesis (Hidaka et al., 1984) was also from Novabiochem (Nottingham, UK). Okadaic acid, a potent inhibitor of two (PP1, PPIB) of the three major protein serine/threonine phosphatases in eukaryotic cells (Cohen et al., 1990) , was from Gibco (Uxbridge, UK). W7 (N-(6-aminohexyl)-5-chloro-l-naphtalene sulfonamide hydrochloride), a calmodulin (CAM) antagonist that inhibits enzyme activities DNA synthesis was indirectly assessed by 3H-methyl-5-thymidine incorporation, and flat-bed scintillation counting (Potter et al., 1987 To check whether thymidine uptake by T47D cells reflected genuine DNA synthesis or was perturbed by the cytoplasmic pooling of 3H-thymidine or its metabolites, experiments were performed in which DNA was extracted and purified from cells grown in the presence or absence of TNFa. Cells in the log phase were cultured in 80 cm2 tissue culture flasks and pulse-labelled with 10tiCiml-' 3H-thymidine for 60 min. DNA was extracted by lysing the cells in 0.2 M NaOH and 1% SDS, and sheared by passing the cell lysate 15 times rapidly through a 25-gauge needle. DNA was purified by a silicon-based DNA purification column (Magic Minipreps, Promega, Madison, USA), which specifically retains DNA of 1-20 Kb length. The column was washed with 02. M NaCl, 20 nM Tris pH 7.5, 5 mM EDTA in 50% ethanol, and DNA eluted with TE buffered preheated to 65-70°C. Purified DNA was dotted onto a positively charged nylon membrane (Printed nylon membrane 1205-403, Pharmacia, UK), UV crosslinked and subsequently the radioactivity counted.
Each experiment was carried out in three replicate wells and was repeated at least three times. Statistical analysis of data was performed using the Mann-Whitney U test.
Cell viability after treatments was tested using the trypan blue exclusion method. Trypsinised cells, as well as cells floating in the medium, were collected and tested to avoid positive selection of viable cells attached to the culture plates.
DNA fluorometry DNA flow-cytometry was performed to investigate the effect of TNFa on cell cycle progression. Cells were cultured for 24 h in the presence of TNFa, 0.05 mg ml-' colchicine, or 2 mM thymidine respectively, and the medium removed. The cells were detached by trypsinisation, washed and resuspended in PBS. DNA was detected by staining with propidium iodide (PI) as described (Taylor, 1980) . Briefly, a stock solution of 2.5 mg ml-' PI in distilled water was diluted 1:10 in 1% Triton X-100 in distilled water. This solution was added to 2 ml of cell suspension to a final concentration of 50jigml-' PI; nuclei were separated from aggregates by filtration through 40 jim nylon mesh and RNA removed by digestion with 0.5 mg ml-' RNase A added directly to the solution. DNA histograms were plotted using a Beckton Dickinson FACSscan. Linear fluorescence data were collected and analysed using the Consort 30 software (Beckton Dickinson, Sunnyvale, CA, USA).
Protein kinase C assay PKC activity was measured using a Gibco PKC assay system (Gibco-Life Technologies Inc., Uxbridge, UK). Exponentially growing cells were cultured in 80 cm2 Nunclon (Nunc, Kam- .._i 30. Subsequently they were lysed with extraction buffer (20 mM (Figure 2 ). This has also been demonstrated by autoradiographic studies suggesting that thymidine incorporation is a good indicator of DNA synthesis in T47D cells (Tamm et al., 1991) . Exposure to TNFa for 24 h inhibited thymidine incorporation of the cells in a dose-dependent manner; 50% inhibition being observed at 1 ng ml-' (Figure 3) . Timecourse studies indicated that significant inhibition of thymidine up-take could only be detected after a minimum of 18-20 h of exposure to TNFa, even when applied at 100 ng ml-' (data not shown). To determine whether either continuous exposure was necessary to achieve inhibition, or an initial exposure induced a delayed response, cells were exposed to TNFa (10 ng ml-') for various time intervals (0.5-10h), the medium changed (i.e. TNFa removed), and thymidine incorporation measured at 6-10 h intervals during a 60 h follow-up period. A minimum initial exposure of 4 h was necessary to detect 50% inhibition of thymidine incorporation 18-24 h later. After 60 h there was no significant difference in thymidine incorporation between TNFx-treated and control cells in this experiment (data not shown).
Cell cycle-specific arrest of T47D cells by TNFa After exposure to TNFa for 24 h, cells accumulated in the GI phase of the cell cycle. The number of cells in G2/M phase decreased from 16% to 9%, and in the S phase from 13% to 7% after exposure to TNFa. The number of cells in GI increased from 60% to 72% (Figure 4 ). For comparison, the effects of colchicine and single step thymidine synchronisation on the DNA profile of T47D cells are also shown in Figure 3 . Colchicine blocks the cell cycle in the mitotic phase while single step thymidine synchronisation inhibits cells during the DNA synthetic phase.
Effect of the PKC agonist, PMA, on T47D cell proliferation and DNA synthesis In contrast to TNFa, PMA stimulates the proliferation of T47 D cells (Figure 1 ). PMA also increased thymidine incorporation at least 2-fold at a concentration of 1 ng ml-I 4.1 (Figure 3 ). When cells were exposed to TNFa in the presence of PMA, the PKC agonist was unable to counteract the inhibitory effect of TNFa on cell growth (Figure 1 ) or thymidine incorporation (data not shown).
TNFa and PMA transiently activates PKC in T47D cells PKC activity peaked 5 min after TNFx treatment in total cellular extracts, and declined to basal levels 30 min posttreatment ( Figure 5 ). A similar, but higher increase was detected 5 min after exposure to PMA ( Figure 5 ). (Figure 8a ,b,c). H8 and OA administered alone did not alter basal thymidine incorporation by these cells. However, W7 exerted a slight, dose-dependent inhibition of thymidine up-take (Figure 8b ).
Discussion
This report shows that whilst T47D cells are resistant to the cytotoxic effects of TNFa, the growth of this breast cancer cell line is reversibly arrested by this cytokine at the G/S transition phase of the cell cycle. This cytostatic effect of TNFa occurs only after a lag period of several hours. We also investigated the involvement of various protein kinases and phosphatases in the early (0-4 h) signal transduction events induced by TNFa. Previous studies addressing the cell cycle specificity of TNFa action have concluded that this cytokine blocks the progression of the cell cycle at the post-synthetic G2 or M phases (Darzynkiewicz et al., 1984; Dealtry et al., 1987; Muro et al., 1991) . However, these studies employed cell lines which responded to TNFa exposure with cell lysis. The proliferation arrest reported in these cases was followed by cell death within hours. In the present study we show that when TNFa acts as a cytostatic rather than a cytotoxic agent it synchronises cells at the GI phase. Our results, therefore, support the hypothesis that the cytostatic and cytotoxic effects of TNFa may be mediated through different molecular pathways (Ruggiero et al., 1987) . It is interesting to note that other cytokines with cytostatic action, including transforming growth factor-P (TGFI), and interleukins 1 and 6, have also been shown to exert a similar synchronising effect at the GI phase on various cell lines (Belizario & Dinarello, 1991; Paciotti & Tamarkin, 1991) suggesting that there may be a common, cytokine-sensitive arrest point in the GI phase.
Despite extensive research, the signal transduction mechanism induced by TNFa is not understood. Numerous reports have implicated PKC in the actions of TNFa on various cell lines. However, the role of PKC in TNFainduced biological responses is currently controversial. The human colon cancer cell line, LoVo, is sensitive to the anti- ; $ . r 2 t ' ; : . v 1 ' 8 @ . , t E . i : : -, . t R ; ; . , < ? -o ; , . : . ; 8 : , , ' ' f i , ; ; * e s , k J X ' 4 v ' ' ; -> ; --: --: ! . . i . . . : . t , S ! t . w ; . . . . , . , @ t , ; : , s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , ; ; ; , . . . . . . _ , , ; * , , : t . @ . ' @ i ' > d S , E S 0 ; ; ; s S , l ; e ' F > . + I F . . . . . . . . . . . . . . ! . . ' ; ' @ . ; : ; . d . ; . ; ' . ' . . . S ; , -. _ . . # . , > , . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 . -! . . I . , -. : . proliferative effect of TNFa, an effect which is blocked by the PKC antagonist, H7 (Matsubara et al., 1990) . PKC is also involved in the action of TNFa on granulocyte-colonystimulating factor receptor (GCSF-R) expression (Elbaz et al., 1991) , progesterone production by rat follicles in vitro (Sancho & Terranova, 1991) and expression of intercellular adhesion molecule 1 (Lane et al., 1990 ). However, a number of TNFa-induced responses appear to be independent of PKC activation. TNFa enhances expression and secretion of group II phospholipase A2 by rat astrocytes, and this response cannot be blocked by PKC inhibitors (Oka & Arrita, 1991) . TNFa-induced expression of macrophage-colony-stimulating factor (MCSF) and interleukin 6 (IL-6) by fibroblasts is also reported to be resistant to PKC inhibitors (Mantovani et al., 1990 and .
In this report we have demonstrated that TNFa rapidly and transiently activates PKC in T47D cells. The functional consequence of PKC activation by TNFoc was further investigated by monitoring the effect of this cytokine on the thymidine incorporation in the presence of H7. PKC activa-TNFm-INDUCED GROWTH ARREST AND SIGNAL TRANSDUCTION 295 tion is not likely to mediate the cytostatic effect of TNFx because inhibition of PKC fails to block the TNFa-induced drop in thymidine incorpation. Moreover, the stimulation of PKC by PMA is associated with increased thymidine up-take and cell proliferation. Both of these effects of PMA are inhibited by H7. Thus, activation of PKC in T47D cells appears to be involved in the initiation of DNA synthesis and cell proliferation. Other molecular events simultaneously induced by TNFa must overcome any putative, growthpromoting activity of PKC.
Multiple signalling events induced by TNFa resulting in distinct cellular responses have recently been reported. In human leukaemia cell lines TNFa directly stimulates PKC, but the TNFa-induced activation of the nuclear transcription factor, NFKB, is not mediated by the activation of the enzyme (Meichle et al., 1990; Feuillard et al., 1991) . In view of the recent discovery of two distinct TNF receptors (Brockhaus et al., 1990) homologous in their extracellular domains but, without any similarity in their intracellular domains it is tempting to speculate that each receptor type may be associated with distinct signalling pathways and biological responses. Thus, PKC activation may be part of the signal transduction for the type of TNF receptor not-involved in the cytostatic effects of TNFa.
Nevertheless, it has to be remembered that PKC is not a single enzyme, but a family of enzymes with at least seven distinct molecular isoforms. These isoforms differ in their activation requirements, substrate specificities, and subcellular localisation. The functional relevance of this enzyme heterogenity is not clear, and an intensive search for isozymespecific functions us currently under way. It has been suggested that PKC inhibitors may also exhibit selective specificity toward different forms of the enzyme (Bosca et al., 1990) . The results of studies using various inhibitors do not, therefore, exclude the possibility that a putative, inhibitorresistant isoform of PKC is involved in TNFx-induced responses which appear to be PKC independent. Furthermore, commercially available PKC inhibitors such as H7 are not strictly enzyme-specific. H7 interacts with the ATP-binding site of the catlytic domain of PKC which shares homology with the ATP-binding site of numerous other ATP-binding proteins. Thus, the possibility exists that such inhibitors may interfere with other cellular functions, in addition to those involving PKC activity and that this 'side-effect' may mask any effect due to PKC inhibition.
To study the functional involvement of other signal transduction pathways in the early events of TNFax signalling, cells have been simultaneously exposed to TNFx and various enzyme inhibitors for 4 h. The results presented here demonstrate that neither cyclic-nucleotide-dependent nor calmodulin-dependent protein kinases are centrally involved in the early signalling events leading to the inhibition of DNA synthesis induced by TNFa. Furthermore, neither of the two major protein phosphatases, PP1 and PP2B, appear to participate in TNFa signal transduction leading to proliferation arrest. Nevertheless, the reservations pointed out in the previous paragraph should be borne in mind when interpreting such data.
Taken together, the data presented in this paper indicate that the cytostatic action of TNFa is exerted at the GI/S transition of the cell cycle, via an intracellular mechanism which may be largely independent of PKC, PKA, calmodulin and the phosphatases PPI or PP2B.
